A Heterologous DNA Priming- Mycobacterium bovis BCG Boosting Immunization Strategy Using Mycobacterial Hsp70, Hsp65, and Apa Antigens Improves Protection against Tuberculosis in Mice
- 1 December 2004
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 72 (12), 6945-6950
- https://doi.org/10.1128/iai.72.12.6945-6950.2004
Abstract
Tuberculosis is responsible for >2 million deaths a year, and the number of new cases is rising worldwide. DNA vaccination combined with Mycobacterium bovis bacillus Calmette Guérin (BCG) represents a potential strategy for prevention of this disease. Here, we used a heterologous prime-boost immunization approach using a combination of DNA plasmids and BCG in order to improve the efficacy of vaccination against Mycobacterium tuberculosis infection in mice. As model antigens, we selected the M. tuberculosis Apa (for alanine-proline-rich antigen) and the immunodominant Hsp65 and Hsp70 mycobacterial antigens combined with BCG. We demonstrated that animals injected with a combination of DNA vectors expressing these antigens, when boosted with BCG, showed increased specific antimycobacterial immune responses compared to animals vaccinated with BCG alone. More importantly, the protection achieved with this regimen was also significantly better than with BCG alone.Keywords
This publication has 31 references indexed in Scilit:
- RNA Encoding the MPT83 Antigen Induces Protective Immune Responses againstMycobacterium tuberculosisInfectionInfection and Immunity, 2004
- A DNA Prime- Mycobacterium bovis BCG Boost Vaccination Strategy for Cattle Induces Protection against Bovine TuberculosisInfection and Immunity, 2003
- Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosisNature Medicine, 2003
- Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developmentsVaccine, 2003
- Mycobacterium bovisBCG Producing Interleukin-18 Increases Antigen-Specific Gamma Interferon Production in MiceInfection and Immunity, 2002
- Clinical and Immune Impact of Mycobacterium bovis BCG Vaccination ScarringInfection and Immunity, 2002
- Priming by DNA Immunization Augments Protective Efficacy ofMycobacterium bovisBacille Calmette-Guerin against TuberculosisInfection and Immunity, 2001
- Protection against tuberculosis by a plasmid DNA vaccineVaccine, 1997
- Protection of rats from adjuvant arthritis by immunization with naked dna encoding for mycobacterial heat shock protein 65Arthritis & Rheumatism, 1997
- BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life.BMJ, 1977